Apaf-1 is a transcriptional target for E2F and p53
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Loss of function of the retinoblastoma protein, pRB, leads to lack of differentiation, hyperproliferation and apoptosis. Inactivation of pRB results in deregulated E2F activity, which in turn induces entry to S-phase and apoptosis. Induction of apoptosis by either the loss of pRB or the deregulation of E2F activity occurs via both p53-dependent and p53-independent mechanisms. The mechanism by which E2F induces apoptosis is still unclear. Here we show that E2F1 directly regulates the expression of Apaf-1, the gene for apoptosis protease-activating factor 1. These results provide a direct link between the deregulation of the pRB pathway and apoptosis. Furthermore, because the pRB pathway is functionally inactivated in most cancers, the identification of Apaf-1 as a transcriptional target for E2F might explain the increased sensitivity of tumour cells to chemotherapy. We also show that, independently of the pRB pathway, Apaf-1 is a direct transcriptional target of p53, suggesting that p53 might sensitize cells to apoptosis by increasing Apaf-1 levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“abnormal proliferation that is induced by loss of RB is often accompanied by increased cell death, through p53-dependent and independent mechanisms49,57,87–91.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [90]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 1×
“Consistent with this role, the pRB pathway is deregulated in most human cancers (reviewed in ref”
BackgroundThe regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · cited 1×
“The best-characterized targets for the pRB family members are the E2F transcription factor”
BackgroundA Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523 · cited 1×
“Increased levels of Apaf-1 as a result of increased E2F activity could provide an explanation for the greater sensitivity of tumour cells to a variety of apoptosis-inducing agents, including chemotherapeutic drug”
BackgroundApaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development
Yoshida, H., Kong, Y.-Y., Yoshida, R., Elia, A. J., Hakem, A., Hakem, R., Penninger, J. M., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81733-x · Cited by 1,138 · cited 1×
“Apaf-1 is an essential stimulator of caspase activity and is required for stress- and oncogene-induced apoptosi”
BackgroundThe coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant
Goldstein, J. C., Waterhouse, N. J., Juin, P., Evan, G. I., & Green, D. R. (2000) · Nature Cell Biology · doi:10.1038/35004029 · Cited by 1,071
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966 · cited 1×
“This suggestion was further substantiated by results—published while this manuscript was undergoing review—showing that Apaf-1 expression is lost in a number of malignant melanomas owing to a combination of allelic loss and transcriptional silencin”
Resultp73 is a human p53-related protein that can induce apoptosis
Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948
p14ARF links the tumour suppressors RB and p53
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H. (1998) · Nature · doi:10.1038/25867 · Cited by 918
Apaf1 (CED-4 Homolog) Regulates Programmed Cell Death in Mammalian Development
Cecconi, F., Alvarez-Bolado, G., Meyer, B. I., Roth, K. A., & Gruss, P. (1998) · Cell · doi:10.1016/s0092-8674(00)81732-8 · Cited by 896 · cited 1×
“Apaf-1 is an essential stimulator of caspase activity and is required for stress- and oncogene-induced apoptosi”
BackgroundSelf-citationp53 and E2F-1 cooperate to mediate apoptosis.
Wu, X., & Levine, A. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3602 · Cited by 839
Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
Qin, X. Q., Livingston, D. M., Kaelin, W. G., & Adams, P. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10918 · Cited by 756
Tumor surveillance via the ARF–p53 pathway
Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.19.2984 · Cited by 717 · cited 1×
“Although ARF seems to have a role in potentiating E2F-induced apoptosis through the stabilization of p53, ectopic expression of ARF results in cell cycle arrest rather than apoptosi”
BackgroundRole for the p53 homologue p73 in E2F-1-induced apoptosis
Irwin, M., Marin, M. C., Phillips, A. C., Seelan, R. S., Smith, D. I., Liu, W., Flores, E. R., Tsai, K. Y., Jacks, T., Vousden, K. H., et al. (2000) · Nature · doi:10.1038/35036614 · Cited by 710
Apaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition
Soengas, M. S., Alarcón, R. M., Yoshida, H., J., A., Giaccia, Hakem, R., Mak, T. W., & Lowe, S. W. (1999) · Science · doi:10.1126/science.284.5411.156 · Cited by 660 · cited 1×
“Apaf-1 is an essential stimulator of caspase activity and is required for stress- and oncogene-induced apoptosi”
BackgroundRegulation of the cyclin E gene by transcription factor E2F1.
Ohtani, K., DeGregori, J., & Nevins, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12146 · Cited by 635
Caspase-9 and APAF-1 form an active holoenzyme
Rodriguez, J., & Lazebnik, Y. (1999) · Genes & Development · doi:10.1101/gad.13.24.3179 · Cited by 569
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M. B., Plunkett, B. S., Han, S. M., Lorincz, A. T., Hedrick, L., & Cho, K. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3988 · Cited by 526 · cited 1×
“To understand whether the increase in Apaf-1 levels was dependent on p53, the analysis was also performed in RKO cells expressing E6 protein from human papilloma virus type 16 (ref”
MethodId2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
Lasorella, A., Noseda, M., Beyna, M., & Iavarone, A. (2000) · Nature · doi:10.1038/35036504 · Cited by 497 · cited 1×
“In our model for apoptosis regulated by the pRB pathway, we have not taken into consideration some recent results on the role of Id2 (ref”
ResultKowalik, T. F., DeGregori, J., Schwarz, J. K., & Nevins, J. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2491-2500.1995 · Cited by 418
The retinoblastoma gene family in differentiation and development
Lipinski, M. M., & Jacks, T. (1999) · Oncogene · doi:10.1038/sj.onc.1203244 · Cited by 405 · cited 1×
“Early-passage (3) MEFs were infected and selected as described above.”
Tsai, K. Y., Hu, Y., Macleod, K. F., Crowley, D., Yamasaki, L., & Jacks, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80274-9 · Cited by 372 · cited 1×
“This model has been supported by data showing that the loss of E2F1 expression suppresses apoptosis and hyperproliferation in Rb -deficient mouse embryo”
MethodZhang, H. S., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)80714-x · Cited by 349
A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
Lissy, N. A., Davis, P. K., Irwin, M., Kaelin, W. G., & Dowdy, S. F. (2000) · Nature · doi:10.1038/35036608 · Cited by 330
CDC25A Phosphatase Is a Target of E2F and Is Required for Efficient E2F-Induced S Phase
Vigo, E., Müller, H., Prosperini, E., Hateboer, G., Cartwright, P., Moroni, M. C., & Helin, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6379 · Cited by 325
Self-citationPelton, R. W., Dickinson, M. E., Moses, H. L., & Hogan, B. L. M. (1990) · Development · doi:10.1242/dev.110.2.609 · Cited by 324
Macleod, K. F., Hu, Y., & Jacks, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01006.x · Cited by 321
Hsieh, J. K., Fredersdorf, S., Kouzarides, T., Martin, K., & Lu, X. (1997) · Genes & Development · doi:10.1101/gad.11.14.1840 · Cited by 278
The E2F transcription factors: key regulators of cell proliferation
Müller, H., & Helin, K. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00030-x · Cited by 260 · cited 1×
“The best-characterized targets for the pRB family members are the E2F transcription factor”
BackgroundSelf-citationInduction of DNA synthesis and apoptosis are separable functions of E2F-1.
Phillips, A. C., Bates, S., Ryan, K. M., Helin, K., & Vousden, K. H. (1997) · Genes & Development · doi:10.1101/gad.11.14.1853 · Cited by 259
Self-citationE2F-1 Potentiates Cell Death by Blocking Antiapoptotic Signaling Pathways
Phillips, A. C., Ernst, M. K., Bates, S., Rice, N. R., & Vousden, K. H. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80387-1 · Cited by 242
Zhou, L., Song, Z., Tittel, J., & Steller, H. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80385-8 · Cited by 196 · cited 1×
“Interestingly, this mechanism seems to have been conserved during evolution, because the expression of HAC-1 , the Drosophila homologue of Apaf-1 , is induced after treatment with ionizing radiatio”
BackgroundOncogene-dependent apoptosis is mediated by caspase-9
Fearnhead, H. O., Rodriguez, J., Govek, E.-E., Guo, W., Kobayashi, R., Hannon, G., & Lazebnik, Y. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13664 · Cited by 172
Hausmann, G., O'Reilly, L. A., van Driel, R., Beaumont, J. G., Strasser, A., Adams, J. M., & Huang, D. C. S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.3.623 · Cited by 141
E2F-1-Induced p53-independent apoptosis in transgenic mice
Holmberg, C., Helin, K., Sehested, M., & Karlström, O. H. (1998) · Oncogene · doi:10.1038/sj.onc.1201915 · Cited by 127
Self-citationPerkins, C. L., Kim, C. N., Fang, G., & Bhalla, K. N. (1998) · PubMed · Cited by 117
Nip, J., Strom, D. K., Fee, B. E., Zambetti, G., Cleveland, J. L., & Hiebert, S. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1049 · Cited by 95
Cited by
Live or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
Pistritto, G., Trisciuoglio, D., Ceci, C., Garufi, A., & D'Orazi, G. (2016) · Aging · doi:10.18632/aging.100934 · Cited by 1,658
“, Apaf-1, caspase-6, and Bid) does not efficiently induce apoptosis per se but rather sensitizes cancer cells to the effects of chemotherapeutic agents, improving the apoptotic outcome [124-127].”
BackgroundOrganelle-specific initiation of cell death pathways
Ferri, K. F., & Kroemer, G. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-e255 · Cited by 1,456
Fridman, J. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1207116 · Cited by 1,401
Metadata
- Authors
- Moroni, M. C., Hickman, E. S., Denchi, E. L., Caprara, G., Colli, E., Cecconi, F., Müller, H., & Helin, K.
- Affiliations
- European Institute of Oncology (IT)
- University of Rome Tor Vergata (IT)
- Nerviano Medical Sciences (IT)
- Corresponding author
- Helin, Kristian
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2001-05-10
- Volume
- 3
- Issue
- 6
- Pages
- 552-558
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W1497251274
- Cited by
- 593
- References
- 38
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 14 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 15 · 2014: 9 · 2013: 22 · 2012: 22
- FWCI
- 27.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Apaf-1, E2F1, p53, retinoblastoma protein, transcriptional regulation, apoptosis, chemosensitivity, cancer cells, S phase entry
- MeSH terms
- Animals, DNA-Binding Proteins, Embryo, Mammalian, Humans, Promoter Regions, Genetic, Proteins, Transcription Factors, Transcription, Genetic, Transcriptional Activation, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cell Cycle Proteins, E2F Transcription Factors, E2F1 Transcription Factor, Mice, Apoptotic Protease-Activating Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.